364 related articles for article (PubMed ID: 30132107)
1. Implication of total tumor size on the prognosis of patients with clinical stage IA lung adenocarcinomas appearing as part-solid nodules: Does only the solid portion size matter?
Kim H; Goo JM; Suh YJ; Park CM; Kim YT
Eur Radiol; 2019 Mar; 29(3):1586-1594. PubMed ID: 30132107
[TBL] [Abstract][Full Text] [Related]
2. Validation of the Eighth Edition Clinical T Categorization System for Clinical Stage IA, Resected Lung Adenocarcinomas: Prognostic Implications of the Ground-Glass Opacity Component.
Kim H; Goo JM; Kim YT; Park CM
J Thorac Oncol; 2020 Apr; 15(4):580-588. PubMed ID: 31877384
[TBL] [Abstract][Full Text] [Related]
3. Lung Adenocarcinomas Manifesting as Radiological Part-Solid Nodules Define a Special Clinical Subtype.
Ye T; Deng L; Wang S; Xiang J; Zhang Y; Hu H; Sun Y; Li Y; Shen L; Xie L; Gu W; Zhao Y; Fu F; Peng W; Chen H
J Thorac Oncol; 2019 Apr; 14(4):617-627. PubMed ID: 30659988
[TBL] [Abstract][Full Text] [Related]
4. Measurement of Multiple Solid Portions in Part-Solid Nodules for T Categorization: Evaluation of Prognostic Implication.
Kim H; Goo JM; Suh YJ; Hwang EJ; Park CM; Kim YT
J Thorac Oncol; 2018 Dec; 13(12):1864-1872. PubMed ID: 30292849
[TBL] [Abstract][Full Text] [Related]
5. Consolidation-to-tumor ratio and tumor disappearance ratio are not independent prognostic factors for the patients with resected lung adenocarcinomas.
Kim H; Goo JM; Kim YT; Park CM
Lung Cancer; 2019 Nov; 137():123-128. PubMed ID: 31568889
[TBL] [Abstract][Full Text] [Related]
6. Sublobar Resection in Stage IA Non-Small Cell Lung Cancer: Role of Preoperative CT Features in Predicting Pathologic Lymphovascular Invasion and Postoperative Recurrence.
Choe J; Kim MY; Yun JK; Lee GD; Kim YH; Choi S; Kim DK
AJR Am J Roentgenol; 2021 Oct; 217(4):871-881. PubMed ID: 33978462
[No Abstract] [Full Text] [Related]
7. Solid Components in the Mediastinal Window of Computed Tomography Define a Distinct Subtype of Subsolid Nodules in Clinical Stage I Lung Cancers.
Yin J; Xi J; Liang J; Zhan C; Jiang W; Lin Z; Xu S; Wang Q
Clin Lung Cancer; 2021 Jul; 22(4):324-331. PubMed ID: 33789831
[TBL] [Abstract][Full Text] [Related]
8. Clinical T categorization in stage IA lung adenocarcinomas: prognostic implications of CT display window settings for solid portion measurement.
Kim H; Goo JM; Kim YT; Park CM
Eur Radiol; 2019 Nov; 29(11):6069-6079. PubMed ID: 31016444
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2012 Mar; 143(3):607-12. PubMed ID: 22104678
[TBL] [Abstract][Full Text] [Related]
10. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
[TBL] [Abstract][Full Text] [Related]
11. Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1365-71. PubMed ID: 22883546
[TBL] [Abstract][Full Text] [Related]
12. Radiologic Predictors for Clinical Stage IA Lung Adenocarcinoma with Ground Glass Components: A Multi-Center Study of Long-Term Outcomes.
Li Z; Ye B; Bao M; Xu B; Chen Q; Liu S; Han Y; Peng M; Lin Z; Li J; Zhu W; Lin Q; Xiong L
PLoS One; 2015; 10(9):e0136616. PubMed ID: 26339917
[TBL] [Abstract][Full Text] [Related]
13. Solid part size is an important predictor of nodal metastasis in lung cancer with a subsolid tumor.
Cho JY; Leem CS; Kim Y; Kim ES; Lee SH; Lee YJ; Park JS; Cho YJ; Lee JH; Lee CT; Yoon HI
BMC Pulm Med; 2018 Sep; 18(1):151. PubMed ID: 30200917
[TBL] [Abstract][Full Text] [Related]
14. Cavity Formation is a Prognostic Indicator for Pathologic Stage I Invasive Lung Adenocarcinoma of ≥3 cm in Size.
Chen C; Fu S; Ni Q; Yiyang W; Pan X; Jing J; Zhao H; Rui W
Med Sci Monit; 2019 Nov; 25():9003-9011. PubMed ID: 31772147
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors of lung adenocarcinoma manifesting as ground glass nodules larger than 3 cm.
Ding H; Wang H; Zhang P; Song N; Chen L; Jiang G
Eur J Cardiothorac Surg; 2019 Jun; 55(6):1130-1135. PubMed ID: 30561606
[TBL] [Abstract][Full Text] [Related]
16. Solid Tumor Size of 2 cm Divides Outcomes of Patients With Mixed Ground Glass Opacity Lung Tumors.
Mimae T; Tsutani Y; Miyata Y; Imai K; Ito H; Nakayama H; Ikeda N; Okada M
Ann Thorac Surg; 2020 May; 109(5):1530-1536. PubMed ID: 31981497
[TBL] [Abstract][Full Text] [Related]
17. A Texture Analysis-Based Prediction Model for Lymph Node Metastasis in Stage IA Lung Adenocarcinoma.
Gu Y; She Y; Xie D; Dai C; Ren Y; Fan Z; Zhu H; Sun X; Xie H; Jiang G; Chen C
Ann Thorac Surg; 2018 Jul; 106(1):214-220. PubMed ID: 29550204
[TBL] [Abstract][Full Text] [Related]
18. Association between high-resolution computed tomography findings and the IASLC/ATS/ERS classification of small lung adenocarcinomas in Japanese patients.
Kudo Y; Matsubayashi J; Saji H; Akata S; Shimada Y; Kato Y; Kakihana M; Kajiwara N; Ohira T; Nagao T; Ikeda N
Lung Cancer; 2015 Oct; 90(1):47-54. PubMed ID: 26259875
[TBL] [Abstract][Full Text] [Related]
19. Predictive Factors for Lymph Node Metastasis in Clinical Stage I Part-Solid Lung Adenocarcinoma.
Lee SY; Jeon JH; Jung W; Chae M; Hwang WJ; Hwang Y; Cho S; Chung JH; Kim K; Jheon S
Ann Thorac Surg; 2021 Feb; 111(2):456-462. PubMed ID: 32652067
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Stratification According to Size and Dominance of Radiologic Solid Component in Clinical Stage IA Lung Adenocarcinoma.
Nakao M; Oikado K; Sato Y; Hashimoto K; Ichinose J; Matsuura Y; Okumura S; Ninomiya H; Mun M
JTO Clin Res Rep; 2022 Feb; 3(2):100279. PubMed ID: 35199054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
